Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Hubert, Méchin"'
Autor:
Sylvie Dejager, Hubert Méchin, François-André Allaert, Annie Chicoye, Catherine Hunault, Christine Moisan, Laura Romengas, Olivier Bugnon, Bruno Vergès, Yves Michiels
Publikováno v:
Advances in Therapy
Advances in Therapy, Springer Verlag (Germany), 2019, 36 (6), pp.1291-1303. ⟨10.1007/s12325-019-00957-y⟩
Advances in therapy, vol. 36, no. 6, pp. 1291-1303
Advances in Therapy, Springer Verlag (Germany), 2019, 36 (6), pp.1291-1303. ⟨10.1007/s12325-019-00957-y⟩
Advances in therapy, vol. 36, no. 6, pp. 1291-1303
Introduction Low-quality communication between patients and care providers and limited patient knowledge of the disease and the therapy are important factors associated with poor glycemic control in patients with type 2 diabetes. We conducted a multi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59b3c9d379b50e9f1ddafa1a79c8b3ac
https://pubmed.ncbi.nlm.nih.gov/31049873
https://pubmed.ncbi.nlm.nih.gov/31049873
Autor:
Christophe Roussel, Cédric Carbonneil, Antoine Audry, Stéphane Burtey, Sandrine Faré, François Langevin, Stéphane Laroche, Emmanuel Luigi, Nicolas Martelli, Hubert Méchin, Grégoire Mercier, Frédéric Rupprecht, Karine Szwarcensztein, André Tanti, Sébastien Woynar, Catherine Zaidman
Publikováno v:
Therapies. 71:69-82
Resume L’evaluation des technologies de sante (ETS) est en pleine evolution et l’interet de prendre en compte des domaines non cliniques est croissant. Si l’aspect medico-economique est communement reconnu, l’evaluation de l’impact organisa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3bc03e8917edce82b43943a6bf0a094f
https://doi.org/10.1016/j.therap.2015.12.003
https://doi.org/10.1016/j.therap.2015.12.003
Autor:
Mathieu Robain, Nicholas Moore, Benoît Dervaux, Denis Comet, Philippe Lechat, Florence Thomas-Delecourt, Christophe Roussel, Véronique Lamarque-Garnier, André Tanti, Karine Szwarcensztein, Cécile Déal, Hubert Méchin, Anne-Françoise Gaudin, Sébastien Marque, Philippe Maugendre, Anne d’Andon, Frantz Thiessard, Gaëlle Nachbaur, Cécile Collignon, Driss Berdaï
Publikováno v:
Thérapie
Thérapie, EDP Sciences, 2018, 73 (1), pp.13-24. ⟨10.1016/j.therap.2017.12.008⟩
Thérapie, EDP Sciences, 2018, 73 (1), pp.13-24. ⟨10.1016/j.therap.2017.12.008⟩
Early market access of health products is associated with a larger number of requests for information by the health authorities. Compared with these expectations, the growing expansion of health databases represents an opportunity for responding to q
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5c127ad860bfd74355899a9daadf72e
http://hdl.handle.net/20.500.12278/11448
http://hdl.handle.net/20.500.12278/11448
Autor:
Florence Thomas-Delecourt, Christophe Roussel, Cécile Déal, Philippe Maugendre, Karine Szwarcensztein, Anne-Françoise Gaudin, Philippe Lechat, André Tanti, Benoît Dervaux, Anne d’Andon, Gaëlle Nachbaur, Frantz Thiessard, Cécile Collignon, Sébastien Marque, Denis Comet, Driss Berdaï, Nicholas Moore, Hubert Méchin, Véronique Lamarque-Garnier, Mathieu Robain
Publikováno v:
Thérapie
Thérapie, EDP Sciences, 2018, 73 (1), pp.1-12. ⟨10.1016/j.therap.2017.12.001⟩
Thérapie, EDP Sciences, 2018, 73 (1), pp.1-12. ⟨10.1016/j.therap.2017.12.001⟩
Resume La mise sur le marche precoce de produits de sante s’accompagne d’une demande accrue d’informations par les autorites de sante. En regard de cette attente, l’enrichissement croissant des bases de donnees de sante represente une opportu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77d4d7653a234a322e05fbe34877c071
https://hal.archives-ouvertes.fr/hal-03163376
https://hal.archives-ouvertes.fr/hal-03163376
Autor:
Jacques Massol, Karine Szwarcensztein, Christophe Roussel, Olivier Grumel, Catherine Rumeau-Pichon, Anne Josseran, David Orlikowski, Anne Grumblat, Alexandre Barna, Eric Vicaut, Benoît Dervaux, Frédérique Debroucker, Cédric Carbonneil, Philippe Maugendre, Karine Chevrie, Hubert Méchin, Jean-Patrick Sales
Publikováno v:
Therapies. 70:63-68
Medical devices (MDs) cover a wide variety of products. They accompany changes in medical practice in step with technology innovations. Innovations in the field of MDs can improve the conditions of use of health technology and/or modify the organisat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d5973270ed10170b08e939cd10efc19
https://doi.org/10.2515/therapie/2015004
https://doi.org/10.2515/therapie/2015004
Autor:
Karine Szwarcensztein, Frédérique Debroucker, Eric Vicaut, Christophe Roussel, Catherine Rumeau-Pichon, Philippe Maugendre, Anne Grumblat, Karine Chevrie, Hubert Méchin, Cédric Carbonneil, Benoît Dervaux, David Orlikowski, Jacques Massol, Jean-Patrick Sales, Anne Josseran, Olivier Grumel, Alexandre Barna
Publikováno v:
Therapies. 70:57-62
Resume Les dispositifs medicaux (DM) couvrent une large variete de produits. Ils accompagnent, au gre des innovations technologiques, l’evolution des pratiques medicales. Les innovations dans le champ du DM peuvent ameliorer les conditions d’util
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::de252a80d76e50673e12ab674aa60cff
https://doi.org/10.2515/therapie/2015002
https://doi.org/10.2515/therapie/2015002
Autor:
Karine Szwarcensztein, Christophe Roussel, Antoine Audry, André Tanti, Hubert Méchin, Nicolas Martelli, Sandrine Fare, Stéphane Burtey, Emmanuel Luigi, Frédéric Rupprecht, François Langevin, Stéphane Laroche, Cédric Carbonneil, Grégoire Mercier, Sébastien Woynar, Catherine Zaidman
Publikováno v:
Thérapie
Thérapie, EDP Sciences, 2016, 71, pp.69-96. ⟨10.1016/j.therap.2016.01.003⟩
Thérapie, EDP Sciences, 2016, 71 (1), pp.83-96. ⟨10.1016/j.therap.2016.01.003⟩
Thérapie, 2016, 71, pp.69-96. ⟨10.1016/j.therap.2016.01.003⟩
Thérapie, EDP Sciences, 2016, 71, pp.69-96. ⟨10.1016/j.therap.2016.01.003⟩
Thérapie, EDP Sciences, 2016, 71 (1), pp.83-96. ⟨10.1016/j.therap.2016.01.003⟩
Thérapie, 2016, 71, pp.69-96. ⟨10.1016/j.therap.2016.01.003⟩
International audience; Health technology assessment (HTA) is a rapidly developing area and the value of taking non-clinical fields into consideration is growing. Although the health-economic aspect is commonly recognised, evaluating organisational i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e251290120c63557e1428c4ead5ecfd1
https://hal-amu.archives-ouvertes.fr/hal-01464976
https://hal-amu.archives-ouvertes.fr/hal-01464976
Autor:
Benoît, Dervaux, Karine, Szwarcensztein, Anne, Josseran, Alexandre, Barna, Cédric, Carbonneil, Karine, Chevrie, Frédérique, Debroucker, Anne, Grumblat, Olivier, Grumel, Jacques, Massol, Philippe, Maugendre, Hubert, Méchin, David, Orlikowski, Christophe, Roussel, Catherine, Rumeau-Pichon, Jean-Patrick, Sales, Eric, Vicaut
Publikováno v:
Therapie. 70(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c5efb1d6aa041e603fe4471e9b1ff16d
https://pubmed.ncbi.nlm.nih.gov/27393397
https://pubmed.ncbi.nlm.nih.gov/27393397